Advertisements

Stocking Stuffers

 

Aurinia Pharmaceuticals Inc. (AUP:CA) Stock Quote

Detailed Quote for Aurinia Pharmaceuticals Inc. (AUP:CA)
$ 26.25   0.41 (+1.59%) Volume: 111.69k 4:00 PM EST 17-Jan-2020
Today 5d 1m 3m 1y more
Last Price
26.25
Change $
0.41
Change %
1.59%
Tick
  
Bid
25.85
Bid Size
200
Ask
26.40
Ask Size
100
Open
25.99
High
26.44
Low
25.74
Prev Close
25.84
Last Trade
01/17/20
Volume
111.69k
52 Wk Hi
28.5900001
52 Wk Low
4.6999998
Market Cap
2.86b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
107,067,447
EPS (TTM)
-0.920000016
PE Ratio
N/A
Exchange
TSX
News and Media for Aurinia Pharmaceuticals Inc. (AUP:CA)
Sector News | Topic News
News for Aurinia Pharmaceuticals Inc. (AUP:CA)
Thu, Dec 12, 2019
9:26 AM Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional Common Shares - Business Wire
Mon, Dec 09, 2019
9:00 PM Aurinia Prices US$166.7 Million Public Offering of Common Shares - Business Wire
6:01 AM Aurinia Announces Public Offering of Common Shares - Business Wire
Thu, Dec 05, 2019
8:16 AM IIROC Trade Resumption - AUP - Canada Newswire
Wed, Dec 04, 2019
4:22 PM IIROC Trading Halt - AUP - Canada Newswire
4:05 PM Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis - Business Wire
Tue, Dec 03, 2019
6:30 AM Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference - Business Wire
Thu, Nov 14, 2019
4:02 PM Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights - Business Wire
Wed, Nov 13, 2019
4:05 PM Aurinia Announces Updates to the Board of Directors - Business Wire
Thu, Nov 07, 2019
6:30 AM Aurinia Completes Voclosporin Drug-Drug Interaction Study Demonstrating No Clinically Significant Interaction With Mycophenolate Mofetil - Business Wire
Wed, Nov 06, 2019
4:05 PM Aurinia Pharmaceuticals to Release Third Quarter 2019 Financial Results on November 14, 2019 - Business Wire
Thu, Oct 31, 2019
6:30 AM Aurinia Announces Initiation of Patient Dosing in Phase 2/3 AUDREY(TM) Clinical Trial for Dry Eye Syndrome - Business Wire
Wed, Oct 16, 2019
6:30 AM Aurinia Reports Last Patient Study Visit in Aurora Phase 3 Lupus Nephritis Study and Provides Update on ATM Facility - Business Wire
Thu, Sep 26, 2019
4:05 PM Aurinia Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference - Business Wire
Fri, Sep 13, 2019
5:11 PM Aurinia Establishes At-the-Market Facility - Business Wire
Fri, Sep 06, 2019
6:05 AM Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference - Business Wire
Tue, Aug 06, 2019
4:02 PM Aurinia Reports Second Quarter 2019 Financial Results and Operational Highlights - Business Wire
Thu, Aug 01, 2019
6:30 AM Aurinia Pharmaceuticals to Release Second Quarter 2019 Financial Results on August 6, 2019 - Business Wire
Thu, Jul 18, 2019
6:30 AM Aurinia Announces Further Strengthening of the Senior Management Team - Business Wire
Thu, Jun 27, 2019
8:02 AM ILJIN Comments on Aurinia Pharmaceutical's Annual Meeting - Business Wire
More News for AUP:CA >>

Tags for Aurinia Pharmaceuticals Inc.

Research stocks or mutual funds related to Aurinia Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to AUP:CA. The keywords below have been associated to AUP:CA by either user submission or electronic means.